• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problems Fluid/Blood Leak (1250); Obstruction of Flow (2423); Infusion or Flow Problem (2964); Material Integrity Problem (2978); Patient Device Interaction Problem (4001)
Patient Problems Nausea (1970); Pain (1994)
Event Date 03/24/2023
Event Type  Injury  
Event Description
Information was received from a healthcare provider (hcp) via a company representative regarding a patient receiving dilaudid/hydromorphone (25 mg/ml at 4 mg/day) via an implanted pump.The patient¿s medical history was chronic pain.The indication for pump use was failed back surgery syndrome and non-malignant pain.It was reported that the patient had a pump replacement about 2-3 weeks ago and stated that things were fine for a while.Then had 5 days of severe pain/lack of effectfrom the pain pump and nausea.The patient was admitted to the hospital for several days.X-rays were normal.The patient was then taken to the or (operating room) for exploration.Cap (catheter access port) aspiration revealed ability to empty the catheter of drug, but there was very poor csf (cerebrospinal fluid) flow.A dye study revealed the appearance of a leak in the spinal area.The catheter was removed and there were no obvious issues.On testing after removal, a leak was noted 2-4 cm from the anchor and a fracture of the catheter was obvious.Foreign material in the end of the catheter was also noted.The environmental, external, or patient factor that may have led or contributed to the issue was noted to be ¿recent pump replacement¿.Following the procedure, the patient¿s pump dose was decreased from 4 mg/day to 1.2 mg/day.
 
Manufacturer Narrative
Concomitant medical products: product id 8709 lot# serial# (b)(4) implanted: (b)(6) 2004 explanted: (b)(6) 2023 product type catheter.Other relevant device(s) are: product id: 8709, serial/lot #: (b)(4), ubd: 07-oct-2005, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key16681414
MDR Text Key312685534
Report Number3004209178-2023-04554
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00763000422615
UDI-Public00763000422615
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/14/2023
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2023
Date Device Manufactured03/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
Patient SexMale
-
-